De nyfødte fik to 4 dages behandlinger med emtricitabin oral opløsning mellem deres første leveuge og 3 måneders alderen med en dosis på 3 mg/ kg én gang dagligt.
In an open-label, non-comparative study, pharmacokinetic data were obtained from 20 neonates of HIV infected mothers who received two 4-day courses of emtricitabine oral solution between the first week of life and 3 months of age at a dose level of 3 mg/ kg once daily.